Knight Therapeutics Коэффициент "короткого" интереса
Что обозначает Коэффициент "короткого" интереса в Knight Therapeutics?
Коэффициент "короткого" интереса Knight Therapeutics, Inc. является 26.62
Какое определение для Коэффициент "короткого" интереса?
Краткосрочный коэффициент - это количество проданных акций, которых нет в наличии, деленное на среднесуточный объем.
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Коэффициент "короткого" интереса компаний в Health Care сектор на TSX по сравнению с Knight Therapeutics
Что делает Knight Therapeutics?
Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada and internationally. It offers Bijuva for the treatment of moderate to severe vasomotor symptoms associated with menopause in women with intact uterus; IMVEXXY to treat postmenopausal moderate to severe dyspareunia; IBSRELA for the treatment of irritable bowel syndrome with constipation in adults; TRELSTAR to treat advanced prostate cancer and for pain associated with endometriosis; ILUVIEN for the treatment of vision loss due to diabetic macular oedema; and NERLYNX to treat early-stage breast cancer. The company also provides Burinex, for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome; PROBUPHINE, to treat opioid addiction; and MOVANTIK for the treatment of opioid-induced constipation. In addition, it offers Vidaza to treat myelodysplastic syndrome; Abraxane for metastatic pancreatic adenocarcinoma; Halaven to treat advanced or metastatic breast cancer; Lenvima for differentiated thyroid cancer, advanced renal cell cancer, and unresectable hepatocellular carcinoma; Ladevina to treat multiple myeloma; Zyvalix for metastatic prostate cancer; Karfib to treat relapsed or refractory multiple myeloma; Leprid for advanced prostate cancer; AmBisome and Cresemba to treat fungal infection; and Impavido for leishmaniasis. Further, the company provides Ursofalk to treat biliary cirrhosis; Salofalk for ulcerative colitis; Fibridoner to treat idiopathic pulmonary fibrosis; Toliscrin for severe acute or resistant chronic infections; and Tobradosa Haler for chronic lung infections. Additionally, it finances other life science companies; and invests in life sciences venture capital funds. The company was incorporated in 2013 and is headquartered in Montreal, Canada.
Компании с коэффициент "короткого" интереса похож на Knight Therapeutics
- Zynex имеет Коэффициент "короткого" интереса из 25.86
- Resolute Forest Products имеет Коэффициент "короткого" интереса из 26.15
- Slate Office REIT имеет Коэффициент "короткого" интереса из 26.20
- Evelo Biosciences Inc имеет Коэффициент "короткого" интереса из 26.22
- Propel имеет Коэффициент "короткого" интереса из 26.23
- Atossa Therapeutics Inc имеет Коэффициент "короткого" интереса из 26.50
- Knight Therapeutics имеет Коэффициент "короткого" интереса из 26.62
- Atreca Inc имеет Коэффициент "короткого" интереса из 26.76
- Shaw Communications имеет Коэффициент "короткого" интереса из 27.01
- Polar Power Inc имеет Коэффициент "короткого" интереса из 27.06
- Wrap Technologies имеет Коэффициент "короткого" интереса из 27.06
- Digimarc имеет Коэффициент "короткого" интереса из 27.07
- Enochian Biosciences имеет Коэффициент "короткого" интереса из 27.23